Samsungbioepis Co,.Ltd is a biopharmaceutical company that specializes in the development and marketing of biosimilars for the treatment of various diseases, including rheumatoid arthritis, psoriasis, and other immunological conditions. Samsungbioepis Co,.Ltd aims to increase patient access to medicines and is focused on becoming a leading biopharmaceutical company with a heritage of innovation and advanced technologies. The company offers BENEPALI, a biosimilar referencing ENBREL, approved for the treatment of various conditions, including rheumatoid arthritis and psoriasis.
Headquarters
76, Songdogyoyuk-ro Yeonsu-gu Incheon
Incheon; Incheon;
Postal Code: 406840
Contact Details: Purchase the Samsung Bioepis Co,.Ltd. (Incheon) report to view the information.
Website: http://www.samsungbioepis.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service